Filter
1586
Filtered Results: 1586
Text search:
assays
Featured
Recommendations
203
New Publications
426
Language
Document type
No document type
898
Guidelines
321
Studies & Reports
183
Manuals
68
Strategic & Response Plan
46
Fact sheets
41
Training Material
14
Situation Updates
8
Resource Platforms
4
Infographics
2
Online Courses
1
Countries / Regions
India
101
Western and Central Europe
46
Global
44
South Africa
32
Germany
26
Eastern Europe
26
Tanzania
24
Africa
23
Latin America and the Carribbean
23
Kenya
22
Nigeria
22
Nepal
21
Brazil
21
Uganda
20
Ethiopia
20
Russia
18
Sierra Leone
17
Syria
17
Malawi
17
Ukraine
16
Liberia
16
Congo, Democratic Republic of
15
Myanmar / Burma
15
Mozambique
14
Zambia
14
Colombia
13
Ghana
13
Rwanda
13
Bangladesh
13
West and Central Africa
11
Middle East and North Africa
10
East and Southern Africa
10
Namibia
10
Haiti
9
Venezuela
9
Philippines
8
South–East Asia Region
8
Argentina
8
Lesotho
7
Senegal
7
Cambodia
7
Asia
7
Central African Republic
7
Burkina Faso
6
Peru
6
Zimbabwe
6
Eastern Europe and Central Asia
6
Indonesia
6
Madagascar
6
Benin
5
Cameroon
5
USA
5
Yemen
5
Angola
5
Mexico
4
El Salvador
4
Chile
4
Bolivia
4
Mali
4
Somalia
4
Ecuador
4
Eswatini/ Swaziland
4
Niger
3
Afghanistan
3
Jordan
3
Saudi Arabia
3
Western Pacific Region
3
Paraguay
3
Lebanon
3
Sri Lanka
3
Sudan
3
Libya
3
Botswana
3
Pakistan
3
Timor Leste/ East Timor
2
China
2
Iran
2
Qatar
2
Guinea
2
Armenia
2
Dominican Republic
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Moldova
2
Egypt
2
Palestine
2
Georgia
2
Chad
2
Bhutan
2
Iraq
2
North Macedonia
1
Tajikistan
1
North Korea
1
Switzerland
1
Turkey
1
Kazakhstan
1
Albania
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Guinea-Bissau
1
North America
1
Uruguay
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Romania
1
Honduras
1
South Sudan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
540
Clinical Guidelines
248
Pharmacy & Technologies
66
Public Health
62
Key Resources
27
Women & Child Health
26
Capacity Building
7
Toolboxes
TB
313
COVID-19
179
HIV
176
NTDs
87
Rapid Response
80
Ebola
49
AMR
32
Refugee
30
Zika
30
Pharmacy
29
Conflict
26
Mental Health
21
NCDs
21
Planetary Health
17
Polio
13
Natural Hazards
10
Caregiver
9
Specific Hazards
8
Cholera
3
Health Financing Toolbox
3
Global Health Education
3
Disability
2
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their ...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
